Role of MRI in prostate cancer detection
暂无分享,去创建一个
[1] N M deSouza,et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.
[2] P. Choyke,et al. Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging. , 2012, Medical physics.
[3] H. Hricak,et al. Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer , 2005, Nature Clinical Practice Urology.
[4] Sadhna Verma,et al. Imaging-guided prostate biopsy: conventional and emerging techniques. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.
[5] T. Sone,et al. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging. , 2011, AJR. American journal of roentgenology.
[6] H. Hricak,et al. The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience. , 2012, AJR. American journal of roentgenology.
[7] John Kurhanewicz,et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. , 2011, Neoplasia.
[8] H. Hricak,et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. , 2007, International journal of radiation oncology, biology, physics.
[9] Piotr Kozlowski,et al. Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences. , 2008, Magnetic resonance imaging.
[10] H. Hricak,et al. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. , 2005, The British journal of radiology.
[11] Yousef Mazaheri,et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.
[12] F. Montorsi,et al. Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? , 2014, World Journal of Urology.
[13] Kemal Tuncali,et al. Image registration for targeted MRI‐guided transperineal prostate biopsy , 2012, Journal of magnetic resonance imaging : JMRI.
[14] Silvia D. Chang,et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, Radiology.
[15] Ciprian Catana,et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging , 2008, Nature Medicine.
[16] H. Hricak,et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. , 2006, Radiology.
[17] Gabor Fichtinger,et al. A workspace‐orientated needle‐guiding robot for 3T MRI‐guided transperineal prostate intervention: evaluation of in‐bore workspace and MRI compatibility , 2013, The international journal of medical robotics + computer assisted surgery : MRCAS.
[18] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[19] Yousef Mazaheri,et al. MRI of the prostate: Clinical relevance and emerging applications , 2011, Journal of magnetic resonance imaging : JMRI.
[20] Jelle O. Barentsz,et al. MRI-guided and robotic-assisted prostate biopsy , 2012, Current opinion in urology.
[21] J Kurhanewicz,et al. Time‐dependent effects of hormone‐deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.
[22] Roberto Passariello,et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. , 2008, European urology.
[23] D. Brizel,et al. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .
[24] John M Pauly,et al. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. , 2006, Magnetic resonance imaging.
[25] Oguz Akin,et al. MR imaging of treated prostate cancer. , 2012, Radiology.
[26] M. Kattan,et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis , 2007, BJU international.
[27] J. Kurhanewicz,et al. Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer , 2012, Journal of magnetic resonance imaging : JMRI.
[28] B. Carey,et al. Imaging for prostate cancer. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).
[29] P. Carroll,et al. Magnetic resonance imaging and spectroscopy of prostate cancer. , 2006, Reviews in urology.
[30] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[31] A. D'Amico,et al. MRI-guided diagnosis and treatment of prostate cancer. , 2001, The New England journal of medicine.
[32] Dennis W J Klomp,et al. Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.
[33] Sharyn I. Katz,et al. MR imaging and MR spectroscopy in prostate cancer management. , 2006, Radiologic clinics of North America.
[34] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[35] Laurence Collette,et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? , 2012, European urology.
[36] M. Kattan,et al. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer , 2012, BJU international.
[37] Jaime Pujadas Oláno,et al. Natural history of early localized prostate cancer. , 2004, JAMA.
[38] V. Pansadoro,et al. Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 2004, La Radiologia medica.
[39] P. Carroll,et al. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. , 1996, AJR. American journal of roentgenology.
[40] I. Floriani,et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. , 2008, AJR. American journal of roentgenology.
[41] Baris Turkbey,et al. Intravoxel incoherent motion MR imaging for prostate cancer: An evaluation of perfusion fraction and diffusion coefficient derived from different b‐value combinations , 2013, Magnetic resonance in medicine.
[42] M D Schnall,et al. Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. , 1996, Academic radiology.
[43] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[44] Lawrence H. Schwartz,et al. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results , 2011, European Radiology.
[45] Baris Turkbey,et al. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. , 2012, AJR. American journal of roentgenology.
[46] Martijn Smeenge,et al. Current status of transrectal ultrasound techniques in prostate cancer , 2012, Current opinion in urology.
[47] Evis Sala,et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.
[48] Martin S Judenhofer,et al. Applications for preclinical PET/MRI. , 2013, Seminars in nuclear medicine.
[49] J. Lagendijk,et al. SAR and power implications of different RF shimming strategies in the pelvis for 7T MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[50] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.
[51] H. D. de Koning,et al. Prostate-Specific Antigen Screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer–Rotterdam , 2010, Journal of the National Cancer Institute.
[52] M. Langer,et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. , 2005, European journal of radiology.
[53] H. Hricak,et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. , 2004, Radiology.
[54] Wei Huang,et al. Feasibility of shutter‐speed DCE‐MRI for improved prostate cancer detection , 2013, Magnetic resonance in medicine.
[55] P. Carroll,et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. , 2004, AJR. American journal of roentgenology.
[56] Baris Turkbey,et al. Multiparametric MRI and prostate cancer diagnosis and risk stratification , 2012, Current opinion in urology.
[57] M. Anscher. PSA kinetics and risk of death from prostate cancer: in search of the Holy Grail of surrogate end points. , 2005, JAMA.
[58] Raj Persad,et al. Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? , 2013, Journal of magnetic resonance imaging : JMRI.
[59] J Kurhanewicz,et al. Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. , 2001, Radiology.
[60] H. Hricak,et al. Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. , 2012, Radiology.
[61] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[62] Ashutosh Kumar Singh,et al. Magnetic resonance imaging‐directed transrectal ultrasonography‐guided biopsies in patients at risk of prostate cancer , 2007, BJU international.
[63] Reducing the influence of b‐value selection on diffusion‐weighted imaging of the prostate: Evaluation of a revised monoexponential model within a clinical setting , 2012, Journal of magnetic resonance imaging : JMRI.
[64] Mark Emberton,et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.
[65] Michael Uder,et al. Magnetic Resonance Image-Guided Biopsies with a High Detection Rate of Prostate Cancer , 2012, TheScientificWorldJournal.
[66] E. Sala,et al. The emerging role of diffusion-weighted MRI in prostate cancer management , 2012, Nature Reviews Urology.